Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) has a cash flow conversion efficiency ratio of 0.032x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥88.11 Million ≈ $12.89 Million USD) by net assets (CN¥2.73 Billion ≈ $399.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (2009–2024)
Cash flow conversion efficiency of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd from 2009 to 2024. This chart illustrates how Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Zhejiang Wolwo Bio-Pharmaceutical Co Ltd stock price for real-time trading data and today's change.
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Zhejiang Wolwo Bio-Pharmaceutical Co Ltd stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Concentrix Corporation
NASDAQ:CNXC
|
0.095x |
|
Pimco Dynamic Income Opportunities Fund
NYSE:PDO
|
0.276x |
|
REMEGEN CO. LTD YC 1
F:REG
|
N/A |
|
Photronics Inc
NASDAQ:PLAB
|
0.044x |
|
Mister Car Wash, Inc. Common Stock
NYSE:MCW
|
0.083x |
|
Triumph Science & Technology Co Ltd
SHG:600552
|
-0.015x |
|
Shenzhen Agricultural Products Co Ltd
SHE:000061
|
0.001x |
|
Douglas Emmett Inc
NYSE:DEI
|
0.040x |
Annual Cash Flow Conversion Efficiency for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (2009–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd from 2009 to 2024. Review 300357 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.46 Billion ≈ $359.80 Million |
CN¥262.44 Million ≈ $38.40 Million |
0.107x | -36.68% |
| 2023-12-31 | CN¥2.30 Billion ≈ $337.10 Million |
CN¥388.32 Million ≈ $56.82 Million |
0.169x | -5.16% |
| 2022-12-31 | CN¥2.03 Billion ≈ $296.63 Million |
CN¥360.28 Million ≈ $52.72 Million |
0.178x | -11.44% |
| 2021-12-31 | CN¥1.80 Billion ≈ $262.90 Million |
CN¥360.58 Million ≈ $52.76 Million |
0.201x | +19.70% |
| 2020-12-31 | CN¥1.53 Billion ≈ $223.62 Million |
CN¥256.22 Million ≈ $37.49 Million |
0.168x | -2.68% |
| 2019-12-31 | CN¥1.35 Billion ≈ $197.83 Million |
CN¥232.93 Million ≈ $34.08 Million |
0.172x | -16.93% |
| 2018-12-31 | CN¥995.42 Million ≈ $145.66 Million |
CN¥206.45 Million ≈ $30.21 Million |
0.207x | +4.43% |
| 2017-12-31 | CN¥801.26 Million ≈ $117.25 Million |
CN¥159.13 Million ≈ $23.29 Million |
0.199x | +6.05% |
| 2016-12-31 | CN¥655.58 Million ≈ $95.93 Million |
CN¥122.77 Million ≈ $17.97 Million |
0.187x | -4.93% |
| 2015-12-31 | CN¥582.91 Million ≈ $85.30 Million |
CN¥114.82 Million ≈ $16.80 Million |
0.197x | +20.85% |
| 2014-12-31 | CN¥513.55 Million ≈ $75.15 Million |
CN¥83.70 Million ≈ $12.25 Million |
0.163x | -29.58% |
| 2013-12-31 | CN¥251.92 Million ≈ $36.86 Million |
CN¥58.30 Million ≈ $8.53 Million |
0.231x | +1.97% |
| 2012-12-31 | CN¥181.38 Million ≈ $26.54 Million |
CN¥41.17 Million ≈ $6.02 Million |
0.227x | +51.24% |
| 2011-12-31 | CN¥127.61 Million ≈ $18.67 Million |
CN¥19.15 Million ≈ $2.80 Million |
0.150x | -6.64% |
| 2010-12-31 | CN¥90.44 Million ≈ $13.23 Million |
CN¥14.54 Million ≈ $2.13 Million |
0.161x | +42.42% |
| 2009-12-31 | CN¥111.89 Million ≈ $16.37 Million |
CN¥12.63 Million ≈ $1.85 Million |
0.113x | -- |
About Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a dust mine drops; Changhao, an artemisia annua pollen allergen sublingual drops; and Changdian, a dust mite skin prick diagnost… Read more